What This Document Is
This document provides a concise overview of common psychiatric medications, categorized into “New Antipsychotics” (2nd generation, atypical) and “Old Antipsychotics” (1st generation, typical). It focuses on medications used in the treatment of schizophrenia and bipolar disorder, outlining key adverse reactions and, crucially, emergency antidotes for potentially life-threatening complications.
Why This Document Matters
This reference is valuable for nursing students and practicing clinicians in psychiatric settings. It serves as a quick-reference guide for understanding potential side effects, recognizing critical conditions like Neuroleptic Malignant Syndrome (NMS) and tardive dyskinesia, and knowing appropriate interventions. It’s most useful during clinical rotations, medication administration, and patient monitoring.
Common Limitations or Challenges
This document is *not* a comprehensive pharmacology textbook. It does not cover dosage, drug interactions, or detailed pharmacokinetic/pharmacodynamic properties. It’s a focused overview intended to highlight critical safety information and common medication classes, not to replace in-depth study or clinical judgment. It also does not cover all psychiatric medications – only antipsychotics are included.
What This Document Provides
The full document includes:
* A listing of specific antipsychotic medications within each generation (Aripiprazole, Chlorpromazine, Clozapine, Olanzapine, Paliperidone, Quetiapine, Risperidone, Ziprasidone).
* Detailed descriptions of adverse reactions, including Extrapyramidal Symptoms (EPS) and their antidotes.
* Information on Neuroleptic Malignant Syndrome (NMS), including symptoms and antidotes.
* Discussion of endocrine side effects like gynecomastia, galactorrhea, and amenorrhea.
* Warnings regarding prolonged QT intervals and seizure risks.
This preview *does not* include specific dosages, detailed mechanisms of action beyond receptor binding, or comprehensive coverage of all potential drug interactions.
